Pattern of practice of re-irradiation for ipsilateral breast tumor recurrence in Italy: a survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)-Reference-Cited by-同舟云学术

Pattern of practice of re-irradiation for ipsilateral breast tumor recurrence in Italy: a survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Published:2023-07-29 Issue: Volume: Page:
ISSN:1699-3055
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Massaccesi Mariangela,Fontana Antonella,Palumbo Isabella^ORCID,Argenone Angela,De Santis Maria Carmen,Masiello Valeria,Pontoriero Antonio,Ciabattoni Antonella

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12094-023-03289-0.pdf

Reference28 articles.

1. World Health Organization Breast cancer incidence, mortality and prevalence worldwide.https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf. (Accessed 29 November 2022).

2. Smanykó V, Mészáros N, Újhelyi M, Fröhlich G, Stelczer G, Major T, et al. Second breast-conserving surgery and interstitial brachytherapy vs salvage mastectomy for the treatment of local recurrences: 5-year results. Brachytherapy. 2019;18:411–9.

3. Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, et al. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg. 2011;253(3):572–9. https://doi.org/10.1097/SLA.0b013e318208fc2a.

4. Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, et al. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation. Radiat Oncol. 2019. https://doi.org/10.1186/s13014-019-1327-8.

5. Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, et al. AIRO breast cancer group best clinical practice 2022 update. Tumori. 2022. https://doi.org/10.1177/03008916221088885. (Erratum in: Tumori. 2022 20:3008916221130201).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerance and Oncological Outcomes of In-Field Reirradiation for Locally Recurrent Breast Cancer: A Long-Term Single-Center Experience;Cancers;2023-09-12